Invex Therapeutics
Manufacturing · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
L 1 38 Rowland St, Subiaco, Western Aust...Phone Number
+61 863820137Website
www.invextherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Invex Therapeutics
Invex Therapeutics Limited is a biopharmaceutical company that specializes in repurposing the approved drug Exenatide for treating neurological conditions associated with raised intracranial pressure, including Idiopathic Intracranial Hypertension (IIH) and acute stroke. The company has trademarked its repurposed drug as Presendin and is currently focusing on its clinical development for IIH. Invex Therapeutics aims to provide effective treatment options for patients suffering from these conditions. Its intended clients include individuals affected by neurological disorders characterized by elevated intracranial pressure.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Invex Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Invex Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Invex Therapeutics
Check out if Invex Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Invex Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Invex Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Invex Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Invex Therapeutics has new funding data
Check if Invex Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Invex Therapeutics
Compare insights from companies similar to Invex Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Invex Therapeutics
<$5M
1-10
Private
$26.2M
2019
N/A
Company Profile Activity
Activity Insights
Invex Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Invex Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Invex Therapeutics.
Invex Therapeutics financials insights
Gather financial insights about Invex Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Share Placement
$26.2M
Invex Therapeutics Tech Stack
A closer look at the technologies used by Invex Therapeutics
Invex Therapeutics News & Media
Favourable Signals For Invex Therapeutics: Numerous Insiders Acquired Stock
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...Investors in Invex Therapeutics (ASX:IXC) have unfortunately lost 56% over the last three years
The truth is that if you invest for long enough, you're going to end up with some losing stocks. But the last three...Positive Signs As Multiple Insiders Buy Invex Therapeutics Stock
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...Here's Why We're Not At All Concerned With Invex Therapeutics' (ASX:IXC) Cash Burn Situation
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Invex Therapeutics
Sign Up For FreeTo access detailed company insights
Invex Therapeutics Limited is a biopharmaceutical company that specializes in repurposing the approved drug Exenatide for treating neurological conditions associated with raised intracranial pressure, including Idiopathic Intracranial Hypertension (IIH) and acute stroke. The company has trademarked its repurposed drug as Presendin and is currently... Read More
